Industry

DUBLIN–(BUSINESS WIRE)–The “Global OTC Topical Drugs Market (2022 Edition) – Analysis By Drug Class, Indication, End User, Formulation, Distribution Channel, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028)” report has been added to ResearchAndMarkets.com’s offering. According to a research report published in August 2022, the Global OTC Topical drugs market … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Medical Device Regulatory Affairs Market By Services, By Service Provider, By Types, By Indication: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The global Medical Device Regulatory Affairs Market was valued at $6,969.7 million in 2021, and is projected to reach $12,247.7 million by 2031, registering a … [Read more…]

PARMA, Italy–(BUSINESS WIRE)–#cannabis–The world’s first start-up to support pharmaceutical companies in every aspect of medical cannabis development and distribution is Italian. Named GQC – Glocal Quality Cannabis, it is one of the federated companies of PQE Group, an international life sciences consulting giant that, for almost 25 years, has been supporting major companies in all … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Social Media in Medical Devices – Thematic Research” report has been added to ResearchAndMarkets.com’s offering. This report will explore the trends behind social media in the medical device industry and provide an industry analysis of the market and competitive landscape. This report identifies companies most likely to succeed in a world filled with … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Peptide Therapeutics Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global peptide therapeutics market is expected to grow from $34.12 billion in 2021 to $37.13 billion in 2022 at a compound annual growth rate (CAGR) of 8.8%. The peptide therapeutics market is expected to reach $52.19 billion in 2026 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Sandhoff disease – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. The “Sandhoff disease – Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Sandhoff disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … [Read more…]

Healthcare teams from diverse European HIV clinics reported that the implementation of the complete long-acting regimen was acceptable, appropriate, and feasible, with the majority of practices achieving optimal implementation within one to three months 81% of people living with HIV who participated in the study reported that the complete long-acting regimen was less stigmatising than … [Read more…]

Rainer Hepberger Joins as a Managing Director LONDON–(BUSINESS WIRE)–Houlihan Lokey (NYSE:HLI), the global investment bank, announced today that Rainer Hepberger has joined the firm as a Managing Director in its European Healthcare team. He will be based in the firm’s London office. Mr. Hepberger joins with more than 15 years of industry experience. Prior to … [Read more…]

Vaccine technologies licensed from Griffith University will be used to develop novel vaccines for increasingly prevalent antibiotic resistant strains Technologies will be initially applied to develop world’s first vaccine against gonorrhea SCHLIEREN, Switzerland–(BUSINESS WIRE)–LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced a license and collaboration agreement … [Read more…]

AMSTERDAM–(BUSINESS WIRE)–Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe diseases, announced today the appointment of Jens Würthner, MD, PhD, as Chief Medical Officer. Dr. Würthner brings Scenic Biotech 20 years of clinical development expertise. His track record includes the successful progression of drug candidates from Phase I initiation … [Read more…]